/RDNT

RDNT Stock - RadNet, Inc.

Q: What is the analyst price target for RDNT?

Analyst price target information is not currently available for RDNT.

Q: What is RDNT's market cap?

Market capitalization information is not currently available for RDNT.

Healthcare|Medical - Diagnostics & Research|NASDAQ

$74.14-2.89%

$2.21 (-2.89%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+24.4%upside

Target: $92.23

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for RDNT

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.50

52W High$85.84

52W Low$45.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$1.83B	$1.62B	$1.43B	$1.32B	$1.07B
Gross Profit	$249.12M	$221.39M	$165.72M	$191.80M	$105.94M
Gross Margin	13.6%	13.7%	11.6%	14.6%	9.9%
Operating Income	$104.62M	$98.70M	$46.36M	$82.55M	$35.68M
Net Income	$2.79M	$3.04M	$10.65M	$24.73M	$-14,840,000
Net Margin	0.2%	0.2%	0.7%	1.9%	-1.4%
EPS	$0.04	$0.05	$0.19	$0.47	$-0.29

Company Overview

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

Visit Website

Earnings History & Surprises

RDNT

Beat Rate

56%

Last 18 quarters

Avg Surprise

-210.1%

EPS vs Estimate

Beats / Misses

10/7

1 met exactly

Latest EPS

$0.20

Q4 2025

EPS Surprise History

Q1 24

+81.8%

$0.20vs$0.11

Q2 24

+177.8%

$0.07vs$-0.09

Q3 24

0.0%

$0.16vs$0.16

Q4 24

+32.5%

$0.18vs$0.14

Q1 25

+4.8%

$0.22vs$0.21

Q2 25

-105.9%

$-0.35vs$-0.17

Q3 25

+82.4%

$0.31vs$0.17

Q4 25

-10.3%

$0.20vs$0.22

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 7, 2026	—	—	—	—
Q1 2026	Feb 26, 2026	$0.19	—	—	—
Q4 2025	Nov 9, 2025	$0.22	$0.20	-10.3%	✗ MISS
Q3 2025	Aug 10, 2025	$0.17	$0.31	+82.4%	✓ BEAT
Q2 2025	May 11, 2025	$-0.17	$-0.35	-105.9%	✗ MISS
Q1 2025	Feb 27, 2025	$0.21	$0.22	+4.8%	✓ BEAT
Q4 2024	Nov 10, 2024	$0.14	$0.18	+32.5%	✓ BEAT
Q3 2024	Aug 7, 2024	$0.16	$0.16	0.0%	= MET
Q2 2024	May 8, 2024	$-0.09	$0.07	+177.8%	✓ BEAT
Q1 2024	Feb 29, 2024	$0.11	$0.20	+81.8%	✓ BEAT
Q4 2023	Nov 8, 2023	$0.06	$0.14	+133.3%	✓ BEAT
Q3 2023	Aug 8, 2023	$0.07	$0.24	+242.9%	✓ BEAT
Q2 2023	May 9, 2023	$-0.07	$-0.08	-14.3%	✗ MISS
Q1 2023	Feb 28, 2023	$0.15	$0.11	-26.7%	✗ MISS
Q4 2022	Nov 9, 2022	$0.16	$0.09	-43.8%	✗ MISS
Q3 2022	Aug 9, 2022	$0.05	$0.15	+200.0%	✓ BEAT
Q2 2022	May 9, 2022	$-0.00	$-0.15	-4602.2%	✗ MISS
Q1 2022	Mar 1, 2022	$0.19	$0.13	-31.6%	✗ MISS
Q4 2021	Nov 8, 2021	$0.20	$0.21	+5.0%	✓ BEAT
Q3 2021	Aug 9, 2021	$0.14	$0.27	+92.9%	✓ BEAT

Frequently Asked Questions about RDNT

What is RDNT's current stock price?

RadNet, Inc. (RDNT) is currently trading at $74.14 per share. The stock has moved -2.89% today.

What is the analyst price target for RDNT?

The average analyst price target for RDNT is $92.25, based on 1 analyst.

What sector is RadNet, Inc. in?

RadNet, Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.

What is RDNT's market cap?

RadNet, Inc. has a market capitalization of $5.72 billion, making it a mid-cap company.

Does RDNT pay dividends?

No, RadNet, Inc. does not currently pay a dividend to shareholders.